Automation Makes Biopharma a Prime Target for Cyber Attacks: Be Ready

Cyber threats emanating from Russia, China and North Korea aimed at the West can affect biotech companies in very real ways, either directly or as collateral damage.

For the biopharma industry, “the situation is pretty bad, and by ‘bad’ I mean absolutely horrific,” Charles Fracchia, co-founder, BIO-ISAC, an international organization that addresses threats to the bio-economy, told BioSpace. Throughout the pharmaceutical industry, “we already are seeing the same problem that took down the Colonial Pipeline last May.”